200 related articles for article (PubMed ID: 32621879)
1. Best Practices for Counseling Adolescents about the Etonogestrel Implant.
Berlan ED; Richards MJ; Vieira CS; Creinin MD; Kaunitz AM; Fraser IS; Edelman A; Mansour D
J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):448-454. PubMed ID: 32621879
[TBL] [Abstract][Full Text] [Related]
2. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
3. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
4. Pediatricians' Attitudes and Beliefs about Long-Acting Reversible Contraceptives Influence Counseling.
Berlan ED; Pritt NM; Norris AH
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):47-52. PubMed ID: 27639750
[TBL] [Abstract][Full Text] [Related]
5. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
Contraception; 2010 Sep; 82(3):256-9. PubMed ID: 20705154
[TBL] [Abstract][Full Text] [Related]
6. Bleeding related to etonogestrel subdermal implant in a US population.
Casey PM; Long ME; Marnach ML; Bury JE
Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
[TBL] [Abstract][Full Text] [Related]
7. Use of etonogestrel implant beyond approved duration: prolonged contraceptive effectiveness.
Ribeiro BC; Nogueira-Silva C; Afonso H; Silva PO; Reis ID
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):309-310. PubMed ID: 30203680
[TBL] [Abstract][Full Text] [Related]
8. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting.
Berlan E; Mizraji K; Bonny AE
Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183
[TBL] [Abstract][Full Text] [Related]
9. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
McNicholas C; Swor E; Wan L; Peipert JF
Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
[TBL] [Abstract][Full Text] [Related]
10. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
Deokar AM; Jackson W; Omar HA
Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
[TBL] [Abstract][Full Text] [Related]
11. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy.
Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S
Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733
[TBL] [Abstract][Full Text] [Related]
12. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
13. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women.
Xu H; Wade JA; Peipert JF; Zhao Q; Madden T; Secura GM
Obstet Gynecol; 2012 Jul; 120(1):21-6. PubMed ID: 22678035
[TBL] [Abstract][Full Text] [Related]
14. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
[TBL] [Abstract][Full Text] [Related]
16. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
17. Etonogestrel implant in adolescents: evaluation of clinical aspects.
Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
Contraception; 2011 Apr; 83(4):336-9. PubMed ID: 21397091
[TBL] [Abstract][Full Text] [Related]
18. Etonogestrel contraceptive implant-associated secondary anorgasmia.
Chapa HO; Ramirez A; Dawson D
Contraception; 2017 Oct; 96(4):254-256. PubMed ID: 28666796
[TBL] [Abstract][Full Text] [Related]
19. Contraceptive implants: pregnancies and problems with removal.
Prescrire Int; 2014 Jun; 23(150):157. PubMed ID: 25121153
[No Abstract] [Full Text] [Related]
20. [Safety profile of etonogestrel contraceptive implant (Nexplanon
Simon C; Agier MS; Béné J; Muller C; Vrignaud L; Marret H; Jonville-Bera AP
J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1074-1082. PubMed ID: 27125380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
